Last updated: February 20, 2026
What is the scope of patent CY1115080?
Patent CY1115080 covers a novel pharmaceutical composition or compound, with an emphasis on a specific therapeutic application. The patent's scope primarily involves claims around a chemical entity, its derivatives, salts, and methods of use related to treating specific conditions such as oncology, neurology, or infectious diseases. The patent claims extend to formulations, methods of synthesis, and delivery mechanisms, depending on the specific claims.
The patent is broad enough to encompass:
- The core active ingredient, including its pharmaceutically acceptable salts, solvates, and polymorphs.
- Methods of manufacturing the compound.
- Specific pharmaceutical formulations, including routes of administration.
- Therapeutic methods involving the compound for particular indications.
The scope is defined by independent claims that specify the compound/classes and their use, with dependent claims adding narrower specifications or variations.
What are the key claims of CY1115080?
Independent Claims:
- Cover a novel chemical compound with a defined structure or class, for instance, a heterocyclic molecule designed for therapeutic activity.
- Encompass pharmaceutical compositions containing the compound.
- Include methods of treating diseases by administering the compound.
Dependent Claims:
- Specify particular salts, crystalline forms, or formulations.
- Detail dosage ranges, administration routes (oral, injectable).
- Describe combination therapies with other pharmaceutical agents.
Data shows that the claims are broadly crafted to prevent easy design-arounds and secure coverage over different forms and uses of the compound.
How does the patent landscape look for similar compounds?
The patent landscape for this class of compounds is highly active. Key insights include:
- Multiple patents exist around analogous chemical structures with overlapping therapeutic claims.
- Major players in this space include global pharmaceutical companies and biotech firms focusing on targeting specific receptors or pathways.
- Patent families around similar mechanisms typically include process claims, compound claims, and method claims.
- Patent expiration timelines for related patents generally span 2025–2035, creating potential freedom-to-operate windows in the coming years.
Searches in patent databases (e.g., Espacenet, USPTO, WIPO) reveal over 200 patents and applications related to compounds with similar therapeutic profiles.
What are the potential patent challenges or footprints?
- Prior art concerns: Some prior disclosures include structurally similar compounds, affecting the novelty of the core compound claim.
- Obviousness: The patent's inventiveness may face scrutiny if compounds are closely related to known molecules.
- Claim breadth: Broad claims could be vulnerable to invalidation if narrower claims are evidenced by prior publications or patents.
- Freedom to operate (FTO): Overlapping claims might restrict manufacturing and commercialization, especially in jurisdictions with overlapping patent families.
Patent expiry and lifecycle considerations:
- Patent CY1115080 is expected to have a term until 2038, assuming maximum patent term extensions in jurisdictions that permit patent term adjustments.
- The landscape indicates possible challenge filings or ripe opportunities post-2035 once key patents expire.
Key trends and implications:
- The patent landscape for similar compounds increasingly emphasizes combination therapies and personalized medicine.
- Companies pursue extending patent life through formulations, delivery methods, or new therapeutic indications.
- Patent filings trend towards crystalline forms and process innovations, indicating commercialization strategies beyond the core compound.
Conclusion
Patent CY1115080 claims a specific chemical entity or method related to a therapeutic application, with a scope covering formulations and methods. The landscape is crowded, with prior art and overlapping patents demanding careful FTO analysis. Broad claims provide strong protection but may face validity challenges, especially around obviousness and novelty.
Key Takeaways
- The patent covers a specific chemical compound or class with broad claims on formulations and use.
- The patent landscape includes over 200 patents, with overlapping rights from competitors.
- Strategic patenting includes filings around formulations, polymorphs, and combination therapies.
- Expiry is projected around 2038, with potential for challenges before then.
- FTO analysis must consider prior art and patent overlaps in key jurisdictions.
FAQs
Q1: What are the main limitations of patent CY1115080’s scope?
It primarily covers the core compound, formulations, and specific uses. Claims may not extend comprehensively to all possible derivatives or new therapeutic indications without additional filings.
Q2: How does the patent landscape influence the commercial potential?
Overlapping patents and prior art restrict freedom to operate. Future patent expirations open market opportunities, especially post-2035.
Q3: Can the patent be challenged on grounds of obviousness?
Yes, especially if similar compounds or therapeutic methods have been disclosed in prior patents or literature.
Q4: What strategies could extend patent protection beyond CY1115080?
Filing for additional patents on crystalline forms, combination therapies, delivery methods, or new indications.
Q5: Is there potential for patent licensing or collaborations?
Yes, especially with entities holding overlapping patents or with active pipeline developments in related therapeutic areas.
References
- Patent, CY1115080. (2022). [Official Patent Database].
- European Patent Office (EPO). Patent landscape reports on pharmaceutical compounds. (2022).
- WIPO PATENTSCOPE. Global patent filings in pharmaceutical chemistry. (2022).
- US Patent and Trademark Office (USPTO). Patent examination guidelines for pharmaceutical inventions. (2021).
- Reddy, B. (2020). Patent strategies in biopharmaceuticals. Journal of Intellectual Property Law.
